PFGIA
ACAD icon

Patriot Financial Group Insurance Agency’s Acadia Pharmaceuticals ACAD Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-300
Closed -$6K – 571
2018
Q1 		$6K Buy
+300
New +$8.31K ﹤0.01% 677

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Patriot Financial Group Insurance Agency's ACAD Position: Q2 2018 in Review

Patriot Financial Group Insurance Agency sold out of Acadia Pharmaceuticals (ACAD) in Q2 2018, closing a stake of 300 shares — an estimated $6K sold.

Patriot Financial Group Insurance Agency first reported a position in ACAD in Q1 2018 and held it in 1 quarter. The position peaked at $6K in Q1 2018. 187 funds tracked by Wall St. Rank hold ACAD as of Q2 2018.

  • Patriot Financial Group Insurance Agency reported no remaining Acadia Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 300 Acadia Pharmaceuticals shares in Q2 2018, an estimated $6K.
  • Patriot Financial Group Insurance Agency first reported a position in Acadia Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Patriot Financial Group Insurance Agency's Acadia Pharmaceuticals position peaked at $6K in Q1 2018.
  • 187 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2018.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2018, filed 14 Aug 2018.